Guided Therapeutics (GTHP) Financial Statements

29 Followers

Guided Therapeutics Financial Overview

Guided Therapeutics's market cap is currently $19.31M. The company's EPS TTM is $-0.04; its P/E ratio is -5.00; Guided Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 767.00K	$ 7.00K	$ 98.00K	$ 13.00K	$ 81.00K
Gross Profit	$ 571.00K	$ 2.00K	$ 36.00K	$ -68.00K	$ 20.00K
Operating Income	$ -2.37M	$ -2.11M	$ -3.46M	$ -3.33M	$ -2.36M
EBITDA	$ -2.47M	$ -1.94M	$ -3.13M	$ -3.69M	$ -919.00K
Net Income	$ -3.20M	$ -2.42M	$ -3.49M	$ -4.34M	$ -2.07M
Balance Sheet
Cash & Short-Term Investments	$ 63.00K	$ 388.00K	$ 591.00K	$ 2.31M	$ 643.00K
Total Assets	$ 1.32M	$ 1.38M	$ 1.67M	$ 3.37M	$ 2.04M
Total Debt	$ 2.94M	$ 2.16M	$ 2.06M	$ 2.26M	$ 2.90M
Net Debt	$ 2.88M	$ 1.77M	$ 1.47M	$ -50.00K	$ 2.26M
Total Liabilities	$ 7.33M	$ 6.27M	$ 5.47M	$ 6.25M	$ 7.49M
Stockholders' Equity	$ -6.01M	$ -4.89M	$ -3.81M	$ -2.88M	$ -5.45M
Cash Flow
Free Cash Flow	$ -1.07M	$ -1.12M	$ -1.75M	$ -1.51M	$ -1.61M
Operating Cash Flow	$ -1.07M	$ -1.12M	$ -1.75M	$ -1.48M	$ -1.59M
Investing Cash Flow	$ -2.00K	$ 0.00	$ 0.00	$ -31.00K	$ -14.00K
Financing Cash Flow	$ 745.00K	$ 916.00K	$ 24.00K	$ 3.18M	$ 2.07M

Currency in USD

Guided Therapeutics Earnings and Revenue History

Income Statement >

Guided Therapeutics Debt to Assets

Balance Sheet >

Guided Therapeutics Cash Flow

Cash Flow >

Guided Therapeutics Forecast EPS vs Actual EPS

Earnings >